CN108159236A - A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application - Google Patents
A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application Download PDFInfo
- Publication number
- CN108159236A CN108159236A CN201711331235.9A CN201711331235A CN108159236A CN 108159236 A CN108159236 A CN 108159236A CN 201711331235 A CN201711331235 A CN 201711331235A CN 108159236 A CN108159236 A CN 108159236A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- pharmaceutical composition
- pharmaceutical chemicals
- bulk pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of pharmaceutical compositions, belong to tcm field.The pharmaceutical composition is the preparation that the bulk pharmaceutical chemicals matched by following weight are prepared：15~60 parts of dragon's blood, 10~55 parts of frankincense, 20~65 parts of myrrh, 25~55 parts of ground bettle, 15~50 parts of Chinese ephedra, 5~40 parts of Radix Notoginseng, 5~45 parts of Rhizoma Chuanxiong, 10~30 parts of native copper, Rhizoma Et Radix Notopterygii 5~25, Radix Angelicae Pubescentis 15~35,3~25 parts of safflower.The present invention also provides the preparation methods and purposes of the pharmaceutical composition.Clinical test proves that pharmaceutical composition compatibility of the present invention is precise and appropriate, and each flavour of a drug complement each other, and have no toxic side effect, and can effectively treat the healing after bone split or the reduction of the fracture, has stronger actual application value.
Description
Technical field
The invention belongs to tcm fields, and in particular to a kind of pharmaceutical composition for treating bone split or fracture and its preparation side
Method and purposes.
Background technology
Fracture means a kind of disease with causing bone parts or being fully broken due to wound or pathology etc..Bone split
Medically it is known as fissure fracture, belongs to one kind in classification of fracture.Children and the elderly are more common in, the young and the middle aged also happens occasionally.
Patient often fractures for a position, and minority is multiple fracture.It can restore original work(through appropriate processing, most patients in time
Can, a few patients can there are different degrees of sequelae.Patient need to generally lie in bed 2-3 months during fractures, to patient's
Life is made troubles.Either curative effect difficulty such as people's will either has certain side effect or the cost higher to existing various drugs.
It now has no and matches dragon's blood, frankincense, myrrh, ground bettle, Chinese ephedra, Radix Notoginseng, Rhizoma Chuanxiong, native copper, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis and safflower
Share the report of the healing after treatment bone split or the reduction of the fracture.
Invention content
The present invention provides a kind of pharmaceutical compositions for treating bone split or fracture and its preparation method and application.
Present invention firstly provides a kind of pharmaceutical compositions, it is that the bulk pharmaceutical chemicals matched containing following weight are prepared
's：
15~60 parts of dragon's blood, 10~55 parts of frankincense, 20~65 parts of myrrh, 25~55 parts of ground bettle, 15~50 parts of Chinese ephedra, three
7 5~40 parts, 5~45 parts of Rhizoma Chuanxiong, 10~30 parts of native copper, 5~25 parts of Rhizoma Et Radix Notopterygii, 15~35 parts of Radix Angelicae Pubescentis, 3~25 parts of safflower.
Further, it is the preparation that the bulk pharmaceutical chemicals matched by following weight are prepared：
15~60 parts of dragon's blood, 10~55 parts of frankincense, 20~65 parts of myrrh, 25~55 parts of ground bettle, 15~50 parts of Chinese ephedra, three
7 5~40 parts, 5~45 parts of Rhizoma Chuanxiong, 10~30 parts of native copper, 5~25 parts of Rhizoma Et Radix Notopterygii, 15~35 parts of Radix Angelicae Pubescentis, 3~25 parts of safflower.
Preferably, it is the preparation being prepared by the raw material of following weight proportion：
30~60 parts of dragon's blood, 20~50 parts of frankincense, 25~45 parts of myrrh, 25~40 parts of ground bettle, 20~40 parts of Chinese ephedra, three
7 15~35 parts, 25~35 parts of Rhizoma Chuanxiong, 15~25 parts of native copper, 17~23 parts of Rhizoma Et Radix Notopterygii, 20~30 parts of Radix Angelicae Pubescentis, 5~20 parts of safflower.
It is highly preferred that it is the preparation being prepared by the raw material of following weight proportion：
40 parts of dragon's blood, 30 parts of frankincense, 30 parts of myrrh, 30 parts of ground bettle, 30 parts of Chinese ephedra, 30 parts of Radix Notoginseng, 30 parts of Rhizoma Chuanxiong, nature
20 parts of copper, 20 parts of Rhizoma Et Radix Notopterygii, 20 parts of Radix Angelicae Pubescentis, 15 parts of safflower.
Aforementioned composition be with dragon's blood, frankincense, myrrh, ground bettle, Chinese ephedra, Radix Notoginseng, Rhizoma Chuanxiong, native copper, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis and
Either water or extractive with organic solvent are active constituent plus auxiliary material acceptable in pharmacy or complementary to the medicinal powder of safflower
The preparation that ingredient is prepared.
" pharmaceutically acceptable auxiliary material " of the present invention refers to the substance being included in addition to the active ingredient (s in dosage form,
Include but are not limited to filler (diluent), lubricant (glidant or antitack agent), dispersant, wetting agent, adhesive, tune
Save agent, solubilizer, antioxidant, bacteriostatic agent, emulsifier, disintegrant etc..Adhesive includes syrup, Arabic gum, gelatin, sorb
(such as microcrystalline cellulose, sodium carboxymethylcellulose, ethyl cellulose or hydroxypropyl are fine for alcohol, tragacanth, cellulose and its derivates
Tie up element etc.), gelatine size, syrup, starch slurry or polyvinylpyrrolidone etc.；Filler include lactose, Icing Sugar, dextrin, starch and
Its derivative, cellulose and its derivates, inorganic calcium salt (such as calcium sulfate, calcium phosphate, calcium monohydrogen phosphate, precipitated calcium carbonate), mountain
Pears alcohol or glycine etc.；Lubricant includes superfine silica gel powder, magnesium stearate, talcum powder, aluminium hydroxide, boric acid, hydrogenated vegetable oil, gathers
Ethylene glycol etc.；Disintegrant includes starch and its derivative (such as sodium carboxymethyl starch, Explotab, pregelatinized starch, improvement
Starch, hydroxypropul starch, cornstarch etc.), polyvinylpyrrolidone or microcrystalline cellulose etc.；Wetting agent includes dodecyl sulphur
Sour sodium, water or alcohol etc.；Antioxidant packages are containing sodium sulfite, sodium hydrogensulfite, sodium pyrosulfite, dibutyl benzoic acid etc.；Bacteriostatic agent packet
Containing 0.5% phenol, 0.3% cresols, 0.5% anesin etc.；Conditioning agent includes hydrochloric acid, citric acid, potassium hydroxide (sodium), Chinese holly
Rafter acid sodium and buffer (including sodium dihydrogen phosphate and disodium hydrogen phosphate) etc.；Emulsifier includes Tween-80, aliphatic acid sorb
Smooth, pluronic gram F-68, lecithin, Fabaceous Lecithin etc.；Solubilizer includes Tween-80, bile, glycerine etc..
The pharmaceutically acceptable complementary ingredient, it has certain physiological activity, but the addition of the ingredient will not change
Become the leading position of above compound or derivative in treatment of diseases, and only play auxiliary effect, these auxiliary work(
Effect is only the utilization to the ingredient known activity, is the usual adjuvant treatment modality of field of medicaments.If by it is above-mentioned it is complementary into
Divide and be used cooperatively with the compounds of this invention, still should belong to the scope of protection of the invention.
Wherein, the preparation is oral preparation.
Wherein, the preparation is powder, decoction, granule, tablet, capsule, oral liquid or pill.
The present invention also provides the preparation methods of aforementioned pharmaceutical compositions, it is comprised the steps of：
1) each raw material is weighed by weight ratio；
2) bulk pharmaceutical chemicals directly beat powder or by bulk pharmaceutical chemicals add water to cook or organic solvent extract, extracting solution concentration, along with medicine
Acceptable auxiliary material or complementary ingredient are prepared into preparation in.
Water extract is used as medicine with medicinal powder, is Chinese medicine tradition occupation mode, after water carries, since the soluble end of water is wide, and energy
It is enough to dissolve out most of active ingredient, drug is made to be easier to be absorbed by the body, is worked faster, such as the form of medication such as decoction；With
Original powder is used as medicine, and the surface area of medicinal powder is larger, is also beneficial to the absorption of active ingredient in vivo in medicinal material, but medicinal material is un-extracted,
Active ingredient still needs to dissolve out re-absorption in vivo, and the opposite water extract that works is slower, but also weakens and be harmful into medicinal material simultaneously
Divide the toxicity caused by human body, be suitable for taking for a long time, such as original powder is prepared into pill form of medication.At present in pharmacy
In the process, ethyl alcohol extracts drug as solvent and one of most commonly seen extracting mode, ethyl alcohol are molten for semi-polarity
Agent, solubility property circle can dissolve water-soluble certain ingredients between polarity and nonpolar solvent, and it is molten also to dissolve nonpolarity
Some ingredients of agent dissolving usually replace decocting with ethyl alcohol extraction, so as to avoid the dissolution of a large amount of invalid components, improve effectively into
The concentration and extraction efficiency divided, but the price of ethyl alcohol is expensive compared with water, in the big production of modern pharmaceutical industry, is produced into save
This, usually or based on decocting.In the case where the water extract of known compositions of the present invention has physiological activity, in order to adapt to
Various productions and demand when using, can optionally water carries, original powder, alcohol extracting or combination thereof method prepare specific agent
Type.
Wherein, specific preparation method is as follows：
Powder：Weigh bulk pharmaceutical chemicals, beat powder, be sieved to get；
Decoction：Weigh bulk pharmaceutical chemicals, decoct, filter to get；
Granule：Bulk pharmaceutical chemicals are weighed, water or organic solvent is added to extract, filtering, filtrate concentration, dry, addition auxiliary material or auxiliary
Helping property ingredient, mixing, granulation, whole grain, it is dry to get；
Tablet：Weigh bulk pharmaceutical chemicals, beat powder, direct powder compression to get；
Capsule：Bulk pharmaceutical chemicals are weighed, water or organic solvent is added to extract, filtering, filtrate is concentrated and dried, and adds in auxiliary material or auxiliary
Property ingredient, mixing, it is encapsulated to get；
The water-bindered pill：Weigh bulk pharmaceutical chemicals, beat powder, be sieved, add in excipient, water pill, it is dry to get；
Honeyed bolus：Weigh bulk pharmaceutical chemicals, beat powder, be sieved, add in honey, pill, it is dry to get；
Dripping pill：Bulk pharmaceutical chemicals are weighed, water or organic solvent is added to extract, filtering adds in matrix in filtrate, mixing heating and melting,
Instill in not miscible condensate liquid condensation to get.
The organic solvent is the ethyl alcohol of various concentration, such as the ethyl alcohol of 25%-95%.
The present invention also provides purposes of the aforementioned pharmaceutical compositions in treatment bone split or fracture drug is prepared.
Qi and blood is the material base of physical activity.《Plain Questions menstruation regulating opinion》It says：" owner of people, blood and gas ear ".《Difficulty is through
22 is difficult》It says：" qi warming body, blood nourishing." gas has warm use, blood has the function of supporting, four limbs bones of the body collectively, the five internal organs six
Internal organs all relies qi and blood to support.Bone is the important component of human body.Certainly also it be unable to do without supplementing nutrition for qi and blood.《Ling Shu Miraculous Pivot or Divine Axis passages through which vital energy circulates
》It says：" part of the body cavity above the diaphragm housing the heart and lungs outlet, the nourishing the bone section with warm boundary between muscles ".《This Tibetan of Ling Shu Miraculous Pivot or Divine Axis piece》It adds：" passages through which vital energy circulates person, thus qi and blood circulation promotion and it is flourish cloudy
Sun moistens muscles and bones, sharp joint person ".It is the important substance of bone of supplementing nutrition to illustrate qi and blood.Passages through which vital energy circulates is unimpeded, and qi and blood reconciles, and bone is just
It can obtain and supplement nutrition and make powerful muscle and bone.Accordingly it is considered that：After fracture, it is necessary to which passages through which vital energy circulates is unimpeded, and qi and blood reconciliation could heal.If
Qi depression to blood stasis, passages through which vital energy circulates occlusion, then derangement of Qi and blood, the broken ends of fractured bone cannot nourish, and just be difficult to heal.《General Records of Holy Universal Relief traumatics fracture door》Cloud：
" people all over the body, defend by blood Ying Qi, recycles infinite or muscles joint, accidentally causes to be traumaticd fracture, then qi and blood stasis pain, must not hinder,
Must not roll over and continue "." arteries and veins person's house of blood in blood arteries and veins, is passed through and is managed in meat, ring Zhou Yishen, because solid outside its human body, led in passages through which vital energy circulates, is energy
Streamer does not lose it often.If because traumatiing fracture, interior dynamic channels and collaterals, the road of blood, must not declare it is logical, siltation do not dissipate, for swell be pain, control and preferably remove evil
It becomes silted up, makes qi and blood circulation, then can answer.Chen Shiduo《The dialectical record of all kinds of diseases and ailments》It says：" blood not become silted up and do not go by reviver, and silt does not go then that bone cannot
It connects.”
Qi and blood is the important substance of bone of supplementing nutrition.After fracture, if qi and blood is vigorous, with regard to broken ends of fractured bone connection can be accelerated；Instead
It, such as insufficiency of vital energy and blood, fractures with regard to refractory conjunction.
《Plain Questions declares a five gas pieces》It says：" Shen controls bone "；《The big opinion of YIN YANG classification of natural phenomena》It says：" kidney producing bone marrow "；《Six sections are hidden as opinion》
Also say：" kidney person,, fill in bone ".The vital essence of kidney is prompted, bone can be given birth to and brought up.The vigorous then bone growth of kidney qi, kidney qi decline
Then bone also fails therewith.
The strong main body sclerotin of pharmaceutical composition of the present invention, and just because of this so that fracture or bone split are better and are
To rehabilitation.
In pharmaceutical composition of the present invention, dragon's blood is monarch drug in a prescription, analgesic therapy of invigorating blood circulation, scattered stasis pain, detumescence and promoting granulation；Frankincense, myrrh are
Ministerial drug, removing blood stasis and hemostasis, myogenic sore, inducing diuresis for removing edema；Assistant is living with ground bettle, Chinese ephedra, Radix Notoginseng, Rhizoma Chuanxiong, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis and safflower
Blood and relieving pain；Acting on affected part again with power the benefits of native copper synthetism helps it to heal rapidly.
Pharmaceutical composition of the present invention can be obviously improved the situation after bone split or the reduction of the fracture, and patient is made to heal, nontoxic secondary work
With with stronger actual application value.
Obviously, the above according to the present invention according to the ordinary technical knowledge and customary means of this field, is not departing from
Under the premise of the above-mentioned basic fundamental thought of the present invention, the modification, replacement or change of other diversified forms can also be made.
The specific embodiment of form by the following examples remakes further specifically the above of the present invention
It is bright.But the range that this should not be interpreted as to the above-mentioned theme of the present invention is only limitted to following example.It is all to be based on the above of the present invention
The technology realized all belongs to the scope of the present invention.
Specific embodiment
The preparation of embodiment 1, medicinal tablet of the present invention
Take dragon's blood 40g, frankincense 30g, myrrh 30g, ground bettle 30g, Chinese ephedra 30g, Radix Notoginseng 30g, Rhizoma Chuanxiong 30g, native copper
20g, Rhizoma Et Radix Notopterygii 20g, Radix Angelicae Pubescentis 20g, safflower 15g, beat powder, direct powder compression is to get tablet.
The preparation of embodiment 2, drug decoction of the present invention
Take dragon's blood 15g, frankincense 55g, myrrh 20g, ground bettle 25g, Chinese ephedra 50g, Radix Notoginseng 40g, Rhizoma Chuanxiong 5g, native copper 10g,
Rhizoma Et Radix Notopterygii 25g, Radix Angelicae Pubescentis 35g, safflower 3g, soak decoction, and merging filtrate is filtered to get decoction.
The preparation of embodiment 3, medicine capsule of the present invention
Take dragon's blood 60g, frankincense 10g, myrrh 65g, ground bettle 55g, Chinese ephedra 15g, Radix Notoginseng 5g, Rhizoma Chuanxiong 45g, native copper 30g,
Rhizoma Et Radix Notopterygii 5g, Radix Angelicae Pubescentis 15g, safflower 25g add water to cook extraction, are condensed into medicinal extract, add in auxiliary material, and mixing is dispensed to get capsule.
The preparation of embodiment 4, the drug water-bindered pill of the present invention
Take dragon's blood 30g, frankincense 50g, myrrh 25g, ground bettle 40g, Chinese ephedra 20g, Radix Notoginseng 35g, Rhizoma Chuanxiong 25g, native copper
15g, Rhizoma Et Radix Notopterygii 23g, Radix Angelicae Pubescentis 20g, safflower 5g, beat powder, sieving, add in excipient, and water pill is dry to get the water-bindered pill.
The preparation of embodiment 5, drug honeyed bolus of the present invention
Take dragon's blood 60g, frankincense 20g, myrrh 45g, ground bettle 25g, Chinese ephedra 40g, Radix Notoginseng 15g, Rhizoma Chuanxiong 35g, native copper
25g, Rhizoma Et Radix Notopterygii 17g, Radix Angelicae Pubescentis 30g, safflower 20g, beat powder, sieving, add in honey, and pill is dry to get honeyed bolus.
The preparation of embodiment 6, medicinal tablet of the present invention
Take dragon's blood 37g, frankincense 32g, myrrh 33g, ground bettle 40g, Chinese ephedra 32g, Radix Notoginseng 22g, Rhizoma Chuanxiong 25g, native copper
20g, Rhizoma Et Radix Notopterygii 15g, Radix Angelicae Pubescentis 25g, safflower 14g, are extracted with ethyl alcohol, obtain ethanol extract, are condensed into medicinal extract, add in starch system
Grain, whole grain, tabletting are to get tablet.
The preparation of embodiment 7, medicinal tablet of the present invention
Take dragon's blood 45g, frankincense 35g, myrrh 35g, ground bettle 33g, Chinese ephedra 30g, Radix Notoginseng 25g, Rhizoma Chuanxiong 30g, native copper
20g, Rhizoma Et Radix Notopterygii 19g, Radix Angelicae Pubescentis 23g, safflower 17g, beat powder, direct powder compression is to get tablet.
The preparation of embodiment 8, medicine oral liquid of the present invention
Take dragon's blood 20g, frankincense 15g, myrrh 50g, ground bettle 50g, Chinese ephedra 20g, Radix Notoginseng 10g, Rhizoma Chuanxiong 10g, native copper
13g, Rhizoma Et Radix Notopterygii 9g, Radix Angelicae Pubescentis 11g, safflower 5g soak decoction, and merging filtrate concentrates, and embedding sterilizes to get oral liquid.
Beneficial effects of the present invention are proved below by way of test example：
Clinical efficacy after 1 medicine composite for curing bone split of the present invention of test example or the reduction of the fracture
1 experiment material
1.1 experimental drug
Pharmaceutical composition of the present invention is prepared by embodiment 1.
1.2 patient data
Case totally 51 is observed, the age is 42 years old average.
2.1 are included in case standard
Through《Doctor trained in Western medicine Illnesses Diagnoses criterion of therapeutical effect》, the patient that is 1. diagnosed as fracture.2. it is diagnosed as the patient of bone split.
2.2 Excluded cases standards
1. pregnant woman, those who are allergic to this drug.
2. it is associated with the severe primaries disease such as angiocarpy, liver, kidney and hemopoietic system, mental patient.
3. all do not meet inclusion criteria, not by regulation medication, it can not judge that curative effect or data be not congruent and affect the treatment or pacify
Full property judgement person.
2.3 curative effects judge
It cures：Joint structure is normal, and symptom disappears, and function is wholly or substantially restored.
It improves：Joint structure is normal, and symptom improves, and funtion part is limited.
It is not cured：Dislocation does not reset, and symptom is without improvement, dysfunction.
2.4 medication
This medicine daily 3 times, it is early, middle and late respectively to take once, it need to be taken with yellow rice wine or red wine, to help the efficacy of a drug, each taking
The weight of drug is equivalent to 3 grams of crude drugs.It takes 1 month.
3 experimental results
| It cures (example) | It improves (example) | It is not cured (example) | Total effective rate | |
| Treatment group | 50 | 1 | 0 | 100% |
The experiment results show that patient takes 1 month visible positive effect of pharmaceutical composition of the present invention, total effective rate 100%,
Pharmaceutical composition of the present invention can effectively improve the situation after bone split or the reduction of the fracture.
Model case after 2 medicine composite for curing bone split of the present invention of test example or the reduction of the fracture
Korea Spro XX, 32 years old, fracture of tibia and fibula when playing soccer after making steel nail to hospital surgical, was informed that needs tear nail open in 8 weeks, is torn open
It needs to fully recover after 6 weeks right and lefts after nail, taking that this medicine felt for 4 weeks can be painstaking on leg, hospital is gone to check, affected part has been cured
It closes, steel nail is taken out in operation then.
To sum up, the strong main body sclerotin of pharmaceutical composition of the present invention, the situation that can be obviously improved after bone split or the reduction of the fracture,
Patient is made to heal, mitigates patient suffering, has no toxic side effect, there is stronger actual application value.
Claims (10)
1. a kind of pharmaceutical composition, it is characterised in that：It is that the bulk pharmaceutical chemicals matched containing following weight are prepared：
15~60 parts of dragon's blood, 10~55 parts of frankincense, 20~65 parts of myrrh, 25~55 parts of ground bettle, 15~50 parts of Chinese ephedra, Radix Notoginseng 5
~40 parts, 5~45 parts of Rhizoma Chuanxiong, 10~30 parts of native copper, 5~25 parts of Rhizoma Et Radix Notopterygii, 15~35 parts of Radix Angelicae Pubescentis, 3~25 parts of safflower.
2. pharmaceutical composition according to claim 1, it is characterised in that：It is prepared by the bulk pharmaceutical chemicals that following weight matches
The preparation formed：
15~60 parts of dragon's blood, 10~55 parts of frankincense, 20~65 parts of myrrh, 25~55 parts of ground bettle, 15~50 parts of Chinese ephedra, Radix Notoginseng 5
~40 parts, 5~45 parts of Rhizoma Chuanxiong, 10~30 parts of native copper, 5~25 parts of Rhizoma Et Radix Notopterygii, 15~35 parts of Radix Angelicae Pubescentis, 3~25 parts of safflower.
3. pharmaceutical composition according to claim 2, it is characterised in that：It is by following weight proportion raw material prepare and
Into preparation：
30~60 parts of dragon's blood, 20~50 parts of frankincense, 25~45 parts of myrrh, 25~40 parts of ground bettle, 20~40 parts of Chinese ephedra, Radix Notoginseng 15
~35 parts, 25~35 parts of Rhizoma Chuanxiong, 15~25 parts of native copper, 17~23 parts of Rhizoma Et Radix Notopterygii, 20~30 parts of Radix Angelicae Pubescentis, 5~20 parts of safflower.
4. pharmaceutical composition according to claim 3, it is characterised in that：It is by following weight proportion raw material prepare and
Into preparation：
40 parts of dragon's blood, 30 parts of frankincense, 30 parts of myrrh, 30 parts of ground bettle, 30 parts of Chinese ephedra, 30 parts of Radix Notoginseng, 30 parts of Rhizoma Chuanxiong, native copper 20
Part, 20 parts of Rhizoma Et Radix Notopterygii, 20 parts of Radix Angelicae Pubescentis, 15 parts of safflower.
5. according to Claims 1 to 4 any one of them pharmaceutical composition, it is characterised in that：It is medicinal powder by bulk pharmaceutical chemicals, original
Expect that the water of medicine or extractive with organic solvent are active constituent, and in pharmacy acceptable auxiliary material or complementary ingredient prepare and
Into preparation.
6. pharmaceutical composition according to claim 5, it is characterised in that：The preparation is oral preparation.
7. pharmaceutical composition according to claim 6, it is characterised in that：The preparation is powder, decoction, granule, piece
Agent, capsule, oral liquid or pill.
8. the preparation method of claim 1~7 any one of them pharmaceutical composition, it is characterised in that：It is comprised the steps of：
1) each raw material is weighed by weight ratio；
2) bulk pharmaceutical chemicals directly beat powder or by bulk pharmaceutical chemicals add water to cook or organic solvent extract, extracting solution concentration, along in pharmacy
Acceptable auxiliary material or complementary ingredient are prepared into preparation.
9. preparation method according to claim 8, it is characterised in that：The preparation method is as follows：
Powder：Weigh bulk pharmaceutical chemicals, beat powder, be sieved to get；
Decoction：Weigh bulk pharmaceutical chemicals, decoct, filter to get；
Granule：Bulk pharmaceutical chemicals are weighed, water or organic solvent is added to extract, filtering, filtrate concentration, dry, addition auxiliary material or complementary
Ingredient, mixing, granulation, whole grain, it is dry to get；
Tablet：Weigh bulk pharmaceutical chemicals, beat powder, direct powder compression to get；
Capsule：Weigh bulk pharmaceutical chemicals, water or organic solvent added to extract, filtering, filtrate is concentrated and dried, add in auxiliary material or it is complementary into
Point, mixing, it is encapsulated to get；
The water-bindered pill：Weigh bulk pharmaceutical chemicals, beat powder, be sieved, add in excipient, water pill, it is dry to get；
Honeyed bolus：Weigh bulk pharmaceutical chemicals, beat powder, be sieved, add in honey, pill, it is dry to get；
Dripping pill：Bulk pharmaceutical chemicals are weighed, water or organic solvent is added to extract, is filtered, matrix is added in filtrate, mixing heating and melting instills
In not miscible condensate liquid condense to get.
10. purposes of claim 1~6 any one of them pharmaceutical composition in treatment bone split or fracture drug is prepared.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711331235.9A CN108159236A (en) | 2017-12-13 | 2017-12-13 | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711331235.9A CN108159236A (en) | 2017-12-13 | 2017-12-13 | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108159236A true CN108159236A (en) | 2018-06-15 |
Family
ID=62525893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711331235.9A Pending CN108159236A (en) | 2017-12-13 | 2017-12-13 | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108159236A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138482A (en) * | 1996-03-25 | 1996-12-25 | 刘建明 | Medicine and bone-growing plaster for treatment of fracture |
-
2017
- 2017-12-13 CN CN201711331235.9A patent/CN108159236A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138482A (en) * | 1996-03-25 | 1996-12-25 | 刘建明 | Medicine and bone-growing plaster for treatment of fracture |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105395577B (en) | A kind of anti-trioxypurine composition and its preparation | |
| CN104524247B (en) | One treats migrainous medical composition and its use | |
| CN108014237A (en) | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application | |
| CN105535495A (en) | Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method | |
| CN114949122A (en) | Traditional Chinese medicine composition for treating blood stasis-yang hyperactivity-phlegm turbidity syndrome hypertension and application thereof | |
| CN108159236A (en) | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application | |
| CN108126077A (en) | A kind of pharmaceutical composition for treating fracture or bone split and its preparation method and application | |
| CN108014236A (en) | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application | |
| CN107998252A (en) | It is a kind of to treat fracture or the pharmaceutical composition of bone split and its preparation method and application | |
| CN108042678A (en) | A kind of pharmaceutical composition for treating bone split or fracture and its preparation method and application | |
| CN106361829B (en) | Traditional Chinese medicine composition and preparation for treating ischemic stroke and preparation method thereof | |
| CN106860717A (en) | It is a kind of to treat infertile medicine | |
| CN108186854A (en) | It is a kind of to treat fracture, pharmaceutical composition of bone split and preparation method thereof | |
| CN107929354A (en) | A kind of pharmaceutical composition for treating calculus and its preparation method and application | |
| CN104257803A (en) | Pharmaceutical composition for treating snore as well as preparation method and application of pharmaceutical composition | |
| CN108014238A (en) | It is a kind of to treat fracture, pharmaceutical composition of bone split and preparation method thereof | |
| CA2656220A1 (en) | Compositions and methods for treating and preventing gastro esophageal reflux disease | |
| CN108126076A (en) | A kind of pharmaceutical composition for treating fracture or bone split and its preparation method and application | |
| CN108785559A (en) | A kind of drug and preparation method thereof for treating respiratory tract infection | |
| CN108042679A (en) | A kind of pharmaceutical composition for treating fracture or bone split and its preparation method and application | |
| CN107998253A (en) | It is a kind of to treat fracture or the pharmaceutical composition of bone split and its preparation method and application | |
| CN102204956A (en) | Chinese medicinal composition used at stroke recovery period and preparation method thereof | |
| CN108014235A (en) | It is a kind of to treat fracture or the pharmaceutical composition of bone split and its preparation method and application | |
| CN102018787B (en) | Blood pressure lowering capsules and preparation process thereof | |
| CN105535658A (en) | Traditional Chinese medicine composition for treating dental ulcer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180615 |